首页> 外文期刊>Pathology >'Aussie normals': an a priori study to develop clinical chemistry reference intervals in a healthy Australian population
【24h】

'Aussie normals': an a priori study to develop clinical chemistry reference intervals in a healthy Australian population

机译:'澳大利亚正常人':一项先验研究,旨在开发健康澳大利亚人口的临床化学参考区间

获取原文
获取原文并翻译 | 示例
           

摘要

Development of reference intervals is difficult, time consuming, expensive and beyond the scope of most laboratories. The Aussie Normals study is a direct a priori study to determine reference intervals in healthy Australian adults. All volunteers completed a health and lifestyle questionnaire and exclusion was based on conditions such as pregnancy, diabetes, renal or cardiovascular disease. Up to 91 biochemical analyses were undertaken on a variety of analytical platforms using serum samples collected from 1856 volunteers. We report on our findings for 40 of these analytes and two calculated parameters performed on the Abbott ARCHITECTci8200/ci16200 analysers. Not all samples were analysed for all assays due to volume requirements or assay/instrument availability. Results with elevated interference indices and those deemed unsuitable after clinical evaluation were removed from the database. Reference intervals were partitioned based on the method of Harris and Boyd into three scenarios, combined gender, males and females and age and gender. We have performed a detailed reference interval study on a healthy Australian population considering the effects of sex, age and body mass. These reference intervals may be adapted to other manufacturer's analytical methods using method transference.
机译:参考间隔的开发困难,耗时,昂贵并且超出了大多数实验室的范围。澳大利亚正常人研究是一项直接的先验研究,旨在确定健康的澳大利亚成年人的参考间隔。所有志愿者均填写了一份健康和生活方式调查表,并根据怀孕,糖尿病,肾病或心血管疾病等情况进行了排除。使用从1856名志愿者那里收集的血清样本,在各种分析平台上进行了91次生化分析。我们报告了对40种这些分析物的发现以及在Abbott ARCHITECTci8200 / ci16200分析仪上执行的两个计算参数。由于体积要求或测定/仪器的可用性,并非所有样品都进行了所有测定的分析。从数据库中删除了干扰指数升高的结果以及临床评估后认为不合适的结果。根据哈里斯和博伊德的方法,将参考区间分为三种情况,即性别,男性和女性以及年龄和性别。考虑到性别,年龄和体重的影响,我们对健康的澳大利亚人口进行了详细的参考区间研究。这些参考区间可以使用方法转移适用于其他制造商的分析方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号